Plasma pharmacokinetics of high‐dose oral busulfan in children and adults undergoing bone marrow transplantation

Bruce Bostrom(Minnesota West Community & Technical College), Bruce R. Blazar(University of Minnesota Medical Center), Amy J. Wagoner Johnson(University of Illinois Urbana-Champaign), Alyssa Bruns(University of Minnesota), Karen Enockson(University of Minnesota)

Pediatric Transplantation

February 20, 2003

10.1034/j.1399-3046.7.s3.2.x

Cited by 36

Related Papers

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

|Nature Medicine|2006|3.6k

Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent

|Science|2017|1k

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

|Blood|2002|496

Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function

|Cell Metabolism|2019|430

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

|Blood|2018|406